Show source-provided references
2. De-Ugarte, L., Yoskovitz, G., Balcells, S., Guerri-Fernandez, R., Martinez-Diaz, S., Mellibovsky, L., Urreizti, R., Nogues, X., Grinberg, D., and Garcia-Giralt, N. (2015). MiRNA profiling of whole trabecular bone: Identification of osteoporosis-related changes in MiRNAs in human hip bones. BMC Med. Genom., 8.
10.1186/s12920-015-0149-2 ↗3. Diaz-Prado, S., Cicione, C., Muinos-Lopez, E., Hermida-Gomez, T., Oreiro, N., Fernandez-Lopez, C., and Blanco, F.J. (2012). Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet. Disord., 13.
10.1186/1471-2474-13-144 ↗4. MicroRNA-320a protects against osteoarthritis cartilage degeneration by regulating the expressions of BMI-1 and RUNX2 in chondrocytes
5. Liu, G.Z., Chen, C., Kong, N., Tian, R., Li, Y.Y., Li, Z., Wang, K.Z., and Yang, P. (2020). Identification of potential miRNA biomarkers for traumatic osteonecrosis of femoral head. J. Cell Physiol.
10.1002/jcp.29467 ↗6. Lian, F., Cui, Y., Zhou, C., Gao, K., and Wu, L. (2015). Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS ONE, 10.
10.1371/journal.pone.0121499 ↗7. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor
10.3892/ol.2017.5863 ↗8. MicroRNA-320a downregulation mediates human liver cancer cell proliferation through the Wnt/beta-catenin signaling pathway
10.3892/ol.2016.5479 ↗9. Cheng, C., Chen, Z.Q., and Shi, X.T. (2014). MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase. Tumor Biol.
10.1007/s13277-013-1546-9 ↗10. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a
10.1080/15384047.2018.1538612 ↗11. Wang, Y., Yang, J., Chen, P., Song, Y., An, W., Zhang, H., Butegeleqi, B., and Yan, J. (2020). MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1. Cancer Med.
10.1002/cam4.2919 ↗12. De-Ugarte, L., Serra-Vinardell, J., Nonell, L., Balcells, S., Arnal, M., Nogues, X., Mellibovsky, L., Grinberg, D., Diez-Perez, A., and Garcia-Giralt, N. (2017). Expression profiling of microRNAs in human bone tissue from postmenopausal women. Hum. Cell.
10.1007/s13577-017-0181-y ↗13. De-Ugarte, L., Balcells, S., Nogues, X., Grinberg, D., Diez-Perez, A., and Garcia-Giralt, N. (2018). Pro-osteoporotic miR-320a impairs osteoblast function and induces oxidative stress. PLoS ONE, 13.
10.1371/journal.pone.0208131 ↗14. MicroRNA-320a Regulates the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting HOXA10
10.1159/000438607 ↗15. Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells
10.5582/bst.2011.v5.2.46 ↗18. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer
10.1007/s13277-015-4771-6 ↗19. TGF-beta and BMP signaling in osteoblast differentiation and bone formation
10.7150/ijbs.2929 ↗20. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma
10.1007/s11999-015-4578-1 ↗